Home/Filings/4/0001235802-18-000019
4//SEC Filing

Farley Brian E 4

Accession 0001235802-18-000019

CIK 0001374128other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 1:18 PM ET

Size

19.6 KB

Accession

0001235802-18-000019

Insider Transaction Report

Form 4
Period: 2018-02-28
Farley Brian E
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$22.76/sh34,510$785,4480 total
    Exercise: $1.24Exp: 2023-03-19Common Stock (34,510 underlying)
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2018-02-28$24.00/sh291,743$7,001,8320 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$5.74/sh10,000$57,4000 total
    Exercise: $18.26Exp: 2026-06-14Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$22.64/sh39,563$895,7060 total
    Exercise: $1.36Exp: 2020-03-24Common Stock (39,563 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$10.62/sh5,000$53,1000 total
    Exercise: $13.38Exp: 2027-06-13Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$23.24/sh28,439$660,9220 total
    Exercise: $0.76Exp: 2022-02-08Common Stock (28,439 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$12.64/sh188,800$2,386,4320 total
    Exercise: $11.36Exp: 2024-12-16Common Stock (188,800 underlying)
Footnotes (7)
  • [F1]Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
  • [F2]This option, which was fully vested on January 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F3]This option, which was fully vested on December 31, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F4]This option, which was fully vested on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F5]This option, which provided for vesting in 48 equal monthly installments commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F6]This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F7]This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.

Issuer

ENTELLUS MEDICAL INC

CIK 0001374128

Entity typeother

Related Parties

1
  • filerCIK 0001306117

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 1:18 PM ET
Size
19.6 KB